查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012036

生物殺線蟲劑市場：全球市場預測（依配方、原料、應用方法、作物類型和通路分類），2026-2032年

Bionematicides Market by Formulation, Source, Application Method, Crop Type, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物殺線蟲劑市場價值將達到 4.3852 億美元，到 2026 年將成長至 5.1723 億美元，到 2032 年將達到 15.0879 億美元，年複合成長率為 19.30%。

主要市場統計數據
基準年 2025 4.3852億美元
預計年份：2026年 5.1723億美元
預測年份：2032年 150879億美元
複合年成長率 (%) 19.30%

本文概述了生物殺線蟲劑的現狀，將線蟲生物學、永續害蟲防治的需求、監管壓力和生產者決策因素連結起來。

生物殺線蟲劑融合了生物科學和作物保護策略，旨在減少線蟲造成的產量損失，同時滿足永續性和監管要求。其技術涵蓋微生物製劑、生物活性天然萃取物以及為確保田間性能穩定而量身定做的配方。隨著種植者和農業相關企業尋求減少對合成殺線蟲劑依賴的方法，人們越來越關注那些能夠在綜合蟲害管理方案中兼顧功效、安全性和操作便利性的產品。

找出正在重塑生物殺線蟲劑創新的變革性變化，包括技術進步、精準噴灑、配方和供應鏈韌性。

生物殺線蟲劑市場正經歷多項變革，其驅動力包括生物技術的進步、傳統殺線蟲劑監管的日益嚴格以及對永續害蟲防治需求的不斷成長。微生物發現領域的創新和天然萃取物的改進提高了現有產品的特異性和環境友善性。同時，製劑科學的進步提高了產品的儲存穩定性，確保了田間應用的可靠性，從而減少了先前阻礙其廣泛應用的性能差異。

評估 2025 年美國關稅變化對生物殺線蟲劑原料、供應連續性、進口趨勢和商業策略的累積影響。

2025年美國政策調整帶來的關稅環境變化，為生物殺線蟲劑價值鏈中的跨境採購、原料採購和庫存管理引入了新的考量。關稅調整影響了進口活性成分和輔料的相對成本，迫使生產商和製劑商重新評估籌資策略和短期採購重點。為此，許多相關人員調整了供應商多元化計劃，並評估了區域生產方案，以降低貿易波動帶來的風險。

我們解讀配方、原料、應用方法、作物類型和分銷管道等方面的訊息，以幫助我們選擇產品並將其推向市場。

細分市場分析概述了一個框架，用於了解產品開發和商業化工作將在哪些領域產生最大影響。以劑型分類，生物殺線蟲劑包括乳化濃縮劑、顆粒劑、液體濃縮劑和可濕性粉劑。每種劑型在使用過程中，其穩定性、輸送和處理方面都存在獨特的挑戰，這些挑戰會影響田間表現和市場接受度。依原料來源分類，生物來源殺線蟲劑細分市場包括生化活性成分、微生物製劑和天然萃取物，其中微生物製劑可進一步細分為細菌、真菌和線蟲捕食者。生物來源決定了註冊流程、品管要求和適用性。

這突顯了影響美洲、歐洲、中東和非洲以及亞太地區商業化和研發重點的區域特定趨勢和採用模式。

區域趨勢對產品設計、法規遵循和商業化策略有著決定性的影響。在美洲，大規模的行栽作物種植系統和以價值主導的獎勵計劃，優先考慮具有明確功效數據並能融入現有穀物和油籽噴灑方案的產品，正在影響著產品的推廣應用。相較之下，歐洲、中東和非洲的生產者面臨嚴格的環境法規和多樣化的農藥使用條件，這要求供應商更加關注殘留特徵、環境影響評估以及在地化的噴灑通訊協定。同時，在亞太地區，種植系統多樣化，農業小規模，產品的可負擔性、易用性和本地推廣支持決定其推廣速度。

分析生物殺線蟲劑領域中推動創新夥伴關係、產品組合差異化、策略許可和市場擴張的主要企業和競爭活動。

生物殺線蟲劑領域的企業策略融合了創新主導的研發、策略夥伴關係和最佳化的通路。專注於生物技術的公司通常致力於菌株發現、概念驗證（PoC）功效驗證和智慧財產權保護，而專業的製劑生產商則將生物活性物質轉化為實用產品，優先考慮產品的穩定性和易用性。同時，成熟的農業用品供應商利用其分銷網路和監管方面的專業知識來擴大業務範圍，他們通常與規模小規模的技術公司合作或獲得其技術授權，以豐富產品系列併拓展市場。

在生物殺線蟲劑領域，我們提供切實可行的建議，幫助產業領導者加速採用、管理監管風險、最佳化價值鏈並提供差異化價值。

行業領導者可以透過在四個相互依存的方面進行投資來加速其影響力：產品性能檢驗、監管和市場進入、供應鏈韌性以及客戶支援。優先在各種環境下進行功效測試並獲取可重複的功效數據，以應對生產者面臨的挑戰，並在推廣網路中建立信任。在真實的農業化學品使用條件下獲得的證據，能夠透過強化商業性宣傳和支持推廣活動中的論述，縮短產品的推廣週期。

為確保穩健性，我們制定了一套嚴謹的調查方法，該方法包括與主要相關人員的訪談、實驗室檢驗、監管環境分析和跨市場比較分析。

本研究整合了來自一手和二手調查的證據，對生物農藥的現狀進行了全面而有力的分析。一手調查計畫包括對生產者、農藝師、製劑生產商、經銷商和監管專家進行結構化訪談，以收集他們對生物農藥有效性、使用限制和購買行為的第一手資訊。此外，本研究還查閱了實驗室檢驗摘要和同行評審文獻，以評估生物農藥的生物學作用機制、殘留特性以及與常見農業實踐的兼容性。

一份全面的總結報告，其中確定了有關生物殺線蟲劑的戰略意義、市場準備、研發、商業化和相關人員合作方面的優先領域。

總之，生物殺線蟲劑的發展軌跡很可能受到科學檢驗、監管政策澄清、價值鏈適應性以及供應商將技術價值轉化為對生產者切實可行的指導的能力等因素的共同影響。多季田間資料以及對與精密農業工具相容性的策略性關注，很可能決定哪些產品能夠成為主流，哪些產品只能停留在小眾市場。此外，那些積極應對監管複雜性並建立具有韌性的生產和分銷網路的公司，在應對政策變化和貿易中斷方面，可能更具優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物殺線蟲劑市場：以劑型分類

  • 乳化濃縮液
  • 顆粒
  • 液體
  • 可濕性粉

第9章：生物殺線蟲劑市場：依原料分類

  • 生物化學
  • 微生物
    • 細菌
    • 真菌
    • 線蟲捕食
  • 天然萃取物

第10章：生物殺線蟲劑市場：依應用方法分類

  • 葉面噴布
  • 燻蒸
  • 種子處理
  • 土壤處理

第11章：生物殺線蟲劑市場：依作物類型分類

  • 田間作物
    • 穀類和穀類食品
    • 油籽/豆類
  • 水果和蔬菜
    • 莓果
    • 葫蘆科植物
    • 堅果
  • 草坪和觀賞植物

第12章：生物殺線蟲劑市場：依通路分類

  • 離線
  • 線上

第13章：生物殺線蟲劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：生物殺線蟲劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：生物殺線蟲劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國生物殺線蟲劑市場

第17章：中國生物殺線蟲劑市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adama Agricultural Solutions Ltd
  • Andermatt Biocontrol AG
  • BASF SE
  • Bayer CropScience AG
  • Bioceres Crop Solutions Corp
  • BIoTech International Limited
  • BioWorks Inc
  • Certis USA LLC
  • Coromandel International Limited
  • Corteva Agriscience
  • Dhanuka Agritech Limited
  • FMC Corporation
  • Gowan Company
  • Koppert
  • Lallemand Inc
  • Marrone Bio Innovations Inc
  • Novozymes AG
  • PI Industries Limited
  • Sumitomo Chemical Co Ltd
  • Syngenta Crop Protection AG
  • T Stanes & Company Limited
  • UPL Limited
  • Valent BioSciences Corporation
  • W Neudorff GmbH KG
Product Code: MRR-43539E5D2D43

The Bionematicides Market was valued at USD 438.52 million in 2025 and is projected to grow to USD 517.23 million in 2026, with a CAGR of 19.30%, reaching USD 1,508.79 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 438.52 million
Estimated Year [2026] USD 517.23 million
Forecast Year [2032] USD 1,508.79 million
CAGR (%) 19.30%

Framing the modern bionematicide landscape by linking nematode biology, sustainable pest control imperatives, regulatory pressure, and grower decision drivers

Bionematicides represent a convergence of biological science and crop protection strategy aimed at reducing nematode-induced yield losses while aligning with sustainability and regulatory expectations. The technology suite ranges from microbe-based agents to bioactive natural extracts and tailored formulations designed to deliver consistent field performance. As growers and agribusinesses seek tools that reduce reliance on synthetic nematicides, the spotlight has shifted to products that balance efficacy, safety, and operational fit within integrated pest management programs.

Scientific advancements in microbial strain selection, formulation microencapsulation, and delivery systems have expanded the practical applications of bionematicides beyond niche uses. Concurrently, regulatory frameworks are evolving to recognize bio-based solutions with differentiated risk profiles, which in turn affects R&D priorities and go-to-market timing. Importantly, growers evaluate these products not only on nematode suppression metrics but also on compatibility with existing agronomic practices, crop value, and economic thresholds, so adoption depends on demonstrable agronomic benefits and clear application protocols.

Transitioning from lab to field requires attention to supply logistics, quality control, and extension support. Consequently, stakeholders across the value chain-from seed companies to distributors and crop advisors-play a role in driving acceptance. In short, bionematicides occupy a strategic space where scientific validation, regulatory clarity, and pragmatic deployment converge to determine real-world impact.

Identifying transformative shifts reshaping bionematicide innovation including technology, precision application, formulation advances, and supply chain resilience

The bionematicide landscape is undergoing several transformative shifts driven by advancements in biotechnology, a tightening regulatory environment for conventional nematicides, and increasing demand for sustainable pest management. Innovations in microbial discovery and the refinement of natural extracts have improved the specificity and environmental profile of available options. At the same time, formulation science has enabled better shelf stability and more reliable field delivery, reducing variability in performance that previously constrained broader adoption.

Concurrently, digital agronomy tools and precision application platforms are reshaping how treatments are deployed. Soil diagnostics, remote sensing for nematode hotspots, and variable-rate application technologies now permit targeted interventions that increase efficacy while containing input costs. As a result, bionematicide providers are aligning product development with precision agronomy capabilities to demonstrate comparative advantages in trials and real-world settings.

Supply chain resilience and strategic partnerships have also become critical. Manufacturers are consolidating distribution relationships and investing in contract production capacity to safeguard continuity under fluctuating raw material conditions and regulatory scrutiny. Furthermore, increasing farmer awareness around residue profiles and environmental outcomes has shifted purchasing behavior toward products with clear sustainability credentials. Taken together, these dynamics are accelerating a maturation process in which scientific credibility, application consistency, and integrated advisory services determine commercial success.

Assessing the cumulative implications of United States tariff changes in 2025 on bionematicide inputs, supply continuity, import dynamics, and commercial strategies

The tariff environment established by United States policy changes in 2025 introduced new considerations for cross-border procurement, raw material sourcing, and inventory management in the bionematicide value chain. Tariff adjustments affected the relative cost of imported active ingredients and excipients, prompting manufacturers and formulators to reassess sourcing strategies and near-term procurement priorities. In response, many stakeholders recalibrated supplier diversification plans and evaluated regional manufacturing options to reduce exposure to trade volatility.

These developments also had practical implications for trade logistics and lead times. Import duties combined with customs processing changes extended the effective replenishment cycle for certain imported inputs, incentivizing higher onshore inventory buffers and the pursuit of domestic substitutes where scientifically feasible. Consequently, commercial teams revisited price positioning and contract terms, while R&D groups intensified efforts to qualify alternative raw materials that deliver equivalent performance with more stable supply characteristics.

In parallel, end-users and distributors adjusted procurement windows and adoption timelines to match the revised cost structures. Such shifts increased demand for transparent supply chain traceability and for providers to offer clearer total cost-of-ownership scenarios. Looking forward, the tariff-driven recalibration underscored the strategic value of supply chain agility, local formulation capacity, and collaborative sourcing arrangements that can mitigate the operational impact of sudden trade policy shifts.

Deciphering segmentation-driven insights across formulation, source, application methods, crop types, and distribution channels to inform product and go-to-market choices

Segmentation analysis provides a framework for understanding where product development and commercialization efforts will have the greatest impact. Based on formulation, bionematicide options include emulsifiable concentrate formats, granules, liquid concentrates, and wettable powders; each presents unique challenges around stability, delivery, and user handling, which affect field performance and adoption dynamics. Based on source, the bionematicide universe comprises biochemical actives, microbial agents, and natural extracts, with microbial solutions further differentiated into bacterial, fungal, and nematophagous organisms; the biological origin drives registration pathways, quality control requirements, and application compatibility.

Based on application method, treatments are designed for foliar spray applications, fumigation, seed treatment modalities, and direct soil treatments, and each method demands specific formulation properties and advisory protocols to achieve consistent results. Based on crop type, deployment strategies vary across field crops, fruits and vegetables, and turf and ornamentals; field crops segment further into cereals and grains and oilseeds and pulses, while fruits and vegetables are commonly split into berries, cucurbits, and tree nuts. These crop distinctions influence tolerances for residues, crop protection calendars, and distribution channel preferences. Finally, based on distribution channel, choices between offline and online pathways shape how educational content, technical support, and repeat purchasing are managed.

Integrating these segmentation lenses reveals clustering of opportunity: formulations that align with preferred application methods for high-value crops command premium technical support needs; microbial sources present strong differentiation but require stringent cold chain and QC regimes; and distribution strategies must reconcile the technical onboarding needs of growers with the convenience and reach of e-commerce platforms. In combination, these segmentation insights should guide prioritization of R&D investments, field trial design, and channel enablement programs to maximize adoption and performance consistency.

Highlighting region-specific dynamics and adoption patterns across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence commercialization and R&D priorities

Regional dynamics exert a decisive influence on product design, regulatory pathways, and commercialization strategies. In the Americas, adoption is shaped by large-scale row crop systems and value-driven incentive programs that favor products with clear efficacy data and integration into existing spray regimens for cereals and oilseeds. Transitioning from this context, growers in Europe, Middle East & Africa contend with stringent environmental regulations and diverse agronomic conditions, prompting suppliers to emphasize residue profiles, environmental impact assessments, and regionally tailored application protocols. Meanwhile, the Asia-Pacific region exhibits a broad spectrum of cropping systems and smallholder contexts, where affordability, ease of use, and local extension support determine the pace of uptake.

These regional contrasts affect how companies prioritize regulatory submissions, field trial networks, and distribution footprints. For instance, which regions require more extensive ecotoxicology packages or longer dossier compilation timelines, and which markets are more receptive to microbial solutions versus natural extracts? Moreover, logistical realities such as cold-chain infrastructure and last-mile distribution create differential commercialization costs across regions. Consequently, a regionally differentiated go-to-market strategy that aligns product attributes with local agronomic practices, regulatory expectations, and channel structures increases the likelihood of sustained adoption and scalable impact.

In practice, successful commercialization often combines localized trial evidence, partnerships with regional distributors or extension networks, and tailored training materials that address local pest pressures and cropping cycles. The interplay between regional regulatory nuance and farmer practice therefore determines the shape and speed of market entry and subsequent growth.

Profiling leading companies and competitive behaviors that drive innovation partnerships, portfolio differentiation, strategic licensing, and channel expansion in bionematicides

Company strategies in the bionematicide arena reflect a mixture of innovation-led R&D, strategic partnerships, and channel orchestration. Biotech-focused firms typically concentrate on strain discovery, proof-of-concept efficacy, and IP protection, while specialty formulators translate biological actives into field-ready products that prioritize stability and ease of application. At the same time, established agricultural suppliers deploy their distribution networks and regulatory experience to scale adoption, often entering collaborative agreements or licensing arrangements with smaller technology owners to broaden product portfolios and market reach.

Across the ecosystem, there is a discernible trend toward vertical collaboration: joint development agreements, contract manufacturing partnerships, and co-branded launches enable faster market access while diluting single-entity risk. These alliances frequently include co-investment in field demonstration programs and grower education initiatives to accelerate farmer confidence. Firms that invest in robust quality systems, traceable supply chains, and clear performance benchmarking tend to differentiate successfully because they reduce buyer uncertainty.

Competitive behavior also reflects a bifurcation between premium differentiated products and lower-cost entry-level solutions. Premium offerings emphasize formulation sophistication, proven multi-season efficacy, and technical services, while entry-level products focus on affordability and ease of access. Companies that align their go-to-market and value propositions with specific customer segments-whether commercial row crop operations or specialized high-value fruit producers-achieve stronger traction. In summary, strategic partnerships, manufacturing resilience, and tailored commercialization play central roles in determining which organizations capture long-term value.

Delivering actionable recommendations for industry leaders to accelerate adoption, manage regulatory risk, optimize supply chains, and capture differentiated value in the bionematicide sector

Industry leaders can accelerate impact by aligning investments across four interdependent dimensions: product performance validation, regulatory and market access, supply chain resilience, and customer enablement. First, prioritize multi-environment efficacy trials and reproducible potency data that address grower pain points and build trust among extension networks. Evidence generated under realistic agronomic conditions strengthens commercial claims and supports extension narratives, thereby shortening the adoption curve.

Second, proactively engage with regulatory authorities and standard-setting organizations to clarify registration pathways and to prepare harmonized dossiers where feasible. Early regulatory engagement reduces surprises and allows for strategic sequencing of market entries. Third, optimize supply chains through supplier diversification, regional fill-and-finish capabilities, and contingency planning to mitigate trade and logistics disruptions. Nearshoring critical manufacturing steps and qualifying alternative raw-material sources can materially reduce operational risk.

Finally, invest in customer enablement programs that couple technical advisory services with digital decision-support tools and clear application guidance. Training agronomists, distributors, and growers enhances proper use and maximizes perceived value. To operationalize these priorities, leaders should consider cross-functional task forces that integrate R&D, regulatory affairs, commercial operations, and supply chain teams so that product development decisions are informed by commercialization realities. Together, these actions will improve product uptake, reduce time-to-value for customers, and create defensible competitive positioning.

Outlining a rigorous research methodology that integrates primary stakeholder interviews, lab validations, regulatory mapping, and cross-market comparative analysis to ensure robustness

This research synthesizes evidence from a mix of primary and secondary inputs to construct a robust and defensible analysis of the bionematicide landscape. The primary research program included structured interviews with growers, agronomists, formulators, distributors, and regulatory experts to capture experiential insights on efficacy expectations, handling constraints, and purchasing behaviors. Complementing this, laboratory validation summaries and peer-reviewed literature were examined to assess biological modes of action, persistence characteristics, and compatibility with common agronomic practices.

Regulatory mapping assessed dossier requirements and typical review timelines across key jurisdictions, while supply chain analysis incorporated procurement lead times, input sourcing patterns, and manufacturing constraints. Comparative case studies were used to illustrate successful commercialization pathways and to surface common failure modes. Throughout the methodology, triangulation was used to reconcile divergent viewpoints and to ensure that recommendations are grounded in both technical validity and commercial feasibility.

Quality control measures included standardized interview guides, double-coding of qualitative responses, and cross-checks of laboratory result interpretations with subject-matter experts. The outcome is a multi-layered evidence base designed to support strategic decision-making for R&D prioritization, market entry sequencing, and channel design.

Concluding synthesis that distills strategic takeaways, market readiness cues, and priority areas for R&D, commercialization, and stakeholder engagement in bionematicides

In closing, the trajectory of bionematicide adoption will be shaped by the interplay of scientific validation, regulatory clarity, supply chain adaptability, and the ability of providers to translate technical value into operationally relevant guidance for growers. Strategic emphasis on multi-season field evidence and compatibility with precision agronomy tools will distinguish products that achieve mainstream acceptance from those that remain niche. Furthermore, companies that preemptively address regulatory complexity and build resilient production and distribution networks will be better positioned to navigate policy shifts and trade disruptions.

Priority areas for investment include formulation work that enhances delivery in diverse soils and climates, microbial strain stewardship that ensures consistent efficacy, and customer-facing services that reduce adoption friction. Collaboration across the value chain-pairing innovators with established commercial platforms and regional extension networks-will significantly reduce time-to-adoption and expand market reach. Ultimately, the most successful strategies will be those that marry technical rigor with pragmatic commercialization planning, ensuring that advances in the laboratory translate into reliable outcomes in the field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bionematicides Market, by Formulation

  • 8.1. Emulsifiable Concentrate
  • 8.2. Granules
  • 8.3. Liquid
  • 8.4. Wettable Powder

9. Bionematicides Market, by Source

  • 9.1. Biochemical
  • 9.2. Microbial
    • 9.2.1. Bacterial
    • 9.2.2. Fungal
    • 9.2.3. Nematophagous
  • 9.3. Natural Extract

10. Bionematicides Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Fumigation
  • 10.3. Seed Treatment
  • 10.4. Soil Treatment

11. Bionematicides Market, by Crop Type

  • 11.1. Field Crops
    • 11.1.1. Cereals & Grains
    • 11.1.2. Oilseeds & Pulses
  • 11.2. Fruits & Vegetables
    • 11.2.1. Berries
    • 11.2.2. Cucurbits
    • 11.2.3. Tree Nuts
  • 11.3. Turf & Ornamentals

12. Bionematicides Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Bionematicides Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bionematicides Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bionematicides Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bionematicides Market

17. China Bionematicides Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adama Agricultural Solutions Ltd
  • 18.6. Andermatt Biocontrol AG
  • 18.7. BASF SE
  • 18.8. Bayer CropScience AG
  • 18.9. Bioceres Crop Solutions Corp
  • 18.10. Biotech International Limited
  • 18.11. BioWorks Inc
  • 18.12. Certis USA LLC
  • 18.13. Coromandel International Limited
  • 18.14. Corteva Agriscience
  • 18.15. Dhanuka Agritech Limited
  • 18.16. FMC Corporation
  • 18.17. Gowan Company
  • 18.18. Koppert
  • 18.19. Lallemand Inc
  • 18.20. Marrone Bio Innovations Inc
  • 18.21. Novozymes AG
  • 18.22. PI Industries Limited
  • 18.23. Sumitomo Chemical Co Ltd
  • 18.24. Syngenta Crop Protection AG
  • 18.25. T Stanes & Company Limited
  • 18.26. UPL Limited
  • 18.27. Valent BioSciences Corporation
  • 18.28. W Neudorff GmbH KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIONEMATICIDES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIONEMATICIDES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIONEMATICIDES MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIONEMATICIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIONEMATICIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIONEMATICIDES MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIONEMATICIDES MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIONEMATICIDES MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIONEMATICIDES MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIONEMATICIDES MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIONEMATICIDES MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIONEMATICIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIONEMATICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIONEMATICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIONEMATICIDES MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIONEMATICIDES MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIONEMATICIDES MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIONEMATICIDES MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIONEMATICIDES MARKET SIZE, BY BIOCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIONEMATICIDES MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIONEMATICIDES MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIONEMATICIDES MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIONEMATICIDES MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIONEMATICIDES MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIONEMATICIDES MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIONEMATICIDES MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIONEMATICIDES MARKET SIZE, BY NEMATOPHAGOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIONEMATICIDES MARKET SIZE, BY NEMATOPHAGOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIONEMATICIDES MARKET SIZE, BY NEMATOPHAGOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIONEMATICIDES MARKET SIZE, BY NATURAL EXTRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIONEMATICIDES MARKET SIZE, BY NATURAL EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIONEMATICIDES MARKET SIZE, BY NATURAL EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIONEMATICIDES MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIONEMATICIDES MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIONEMATICIDES MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUMIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUMIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIONEMATICIDES MARKET SIZE, BY FUMIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIONEMATICIDES MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIONEMATICIDES MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIONEMATICIDES MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIONEMATICIDES MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIONEMATICIDES MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIONEMATICIDES MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIONEMATICIDES MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIONEMATICIDES MARKET SIZE, BY CEREALS & GRAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIONEMATICIDES MARKET SIZE, BY CEREALS & GRAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIONEMATICIDES MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIONEMATICIDES MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIONEMATICIDES MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIONEMATICIDES MARKET SIZE, BY BERRIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIONEMATICIDES MARKET SIZE, BY BERRIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIONEMATICIDES MARKET SIZE, BY BERRIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIONEMATICIDES MARKET SIZE, BY CUCURBITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIONEMATICIDES MARKET SIZE, BY CUCURBITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIONEMATICIDES MARKET SIZE, BY CUCURBITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIONEMATICIDES MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIONEMATICIDES MARKET SIZE, BY TREE NUTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIONEMATICIDES MARKET SIZE, BY TREE NUTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIONEMATICIDES MARKET SIZE, BY TURF & ORNAMENTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIONEMATICIDES MARKET SIZE, BY TURF & ORNAMENTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIONEMATICIDES MARKET SIZE, BY TURF & ORNAMENTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIONEMATICIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIONEMATICIDES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIONEMATICIDES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIONEMATICIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIONEMATICIDES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIONEMATICIDES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIONEMATICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIONEMATICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIONEMATICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BIONEMATICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIONEMATICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIONEMATICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIONEMATICIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA BIONEMATICIDES MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA BIONEMATICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA BIONEMATICIDES MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIONEMATICIDES MARKET SIZE, BY FIELD CROPS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIONEMATICIDES MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIONEMATICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)